Missing/wrong data? Edit Wikidata item
Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma
scientific article published on 19 December 2019
Author/s
Work details
Publication date:
December 19, 2019
Language:
Unknown
Country of origin:
Unknown
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.